Position in AMGN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$363,568
+$10,311 QoQ
Shares Held
1,004
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,407
of 3,140 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TILIA FIDUCIARY PARTNERS, INC. holds $5,545,661 across 5 Drug Manufacturers - General names. AMGN ranks #5 (6.6% of the industry book) .
All Filings in AMGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,568 | 1,004 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $353,257 | 1,004 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $354,804 | 1,084 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $314,088 | 1,113 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $327,792 | 1,174 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $364,825 | 1,171 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $324,757 | 1,246 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $400,829 | 1,244 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $376,502 | 1,205 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $355,968 | 1,252 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $360,025 | 1,250 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $337,293 | 1,255 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $255,767 | 1,152 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $285,265 | 1,180 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $309,127 | 1,177 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $264,845 | 1,175 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $285,390 | 1,173 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $258,263 | 1,068 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $239,818 | 1,066 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||